XENE
Xenon Pharmaceuticals
$58.80
−$0.18 (−0.31%)Sep 10, 2026
Key metrics
The numbers that frame XENE today
- Market cap
- $5.69B
- P/E (TTM)
- -13.9
- EV / FCF
- -16.5
- ROIC
- -58.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $35.60
- 52wk High
- $72.66
Growth
Revenue and earnings trend for XENE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XENE
Is Xenon Pharmaceuticals a good buy?
Hold. Xenon Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Xenon Pharmaceuticals is selling at a high price.
What is the market capitalization of XENE?
Xenon Pharmaceuticals's market capitalization is $5.69B.
What is the P/E ratio for XENE stock?
Xenon Pharmaceuticals's current P/E ratio is -13.9.
What is the 52-week high for XENE stock?
The 52-week high for Xenon Pharmaceuticals is $72.66. The current close of $58.80 is 19.1% below that high.
What is the 52-week low for XENE stock?
The 52-week low for Xenon Pharmaceuticals is $35.60. The current close of $58.80 is 65.2% above that low.
Does XENE stock pay dividends?
Xenon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XENE?
Xenon Pharmaceuticals's Debt / Equity ratio is 0.01.